Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-000024

Director bought 40 shares at $6.51 ($260)

  • Director acquired 363,611 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eberwein Jeffrey E. Director 2016-12-30 Purchase +40 $6.51 $260 69,911 I: show line 1 in the form
Eberwein Jeffrey E. Director 2016-12-30 Other acquisition +363,611 $50.00 $18,180,550 363,611 I: show line 2 in the form
Open-market purchases · 40 sh · avg $6.51 · $260

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eberwein Jeffrey E. Director 2016-12-30 Other disposition · 5% Convertible Note due May 2017 −0 $5,000,000.00 $0 0 I: show line 3 in the form
Loading xslF345X03/form410211002_01042017.xml…